Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
LARVOL Launches Cancer-Focused Social Listening Platform
LARVOL, leading provider of data and intelligence solutions for the pharmaceutical and biotech industry, today […]
Cancer-Killing Virus Therapy Shows Promise Against Inoperable Skin Cancers
Early results show that a new combination drug therapy is safe and effective against advanced […]
Exscientia Announces First AI-Designed Immuno-Oncology Drug to Enter Clinical Trials
Exscientia, a leading artificial intelligence (AI)-driven pharmatech company, today announced the first AI-designed molecule for […]
Empatica First to Receive European CE Mark for Detecting Early Symptoms of COVID-19 Using Wearables
Digital biomarker and medical device company Empatica is awarded CE-certification for its Aura system to detect and […]
NHS Digital Selects Scandit’s Clinical Quality Computer Vision Technology to Digitise the Covid-Testing Process
Scandit, the leading technology platform for mobile computer vision and augmented reality (AR) solutions for […]
Antiparasitic Drug Could Prevent Coronavirus Lung Damage
A common antiparasitic drug could block lung damage in people with coronavirus, according to new […]
Hawaii Cancer Care Deploys AI-Screening Tool VIPER ™
Hawaii Cancer Care and Deep Lens today announced a partnership that will expand the clinical trial offering for […]
Healx Using Artificial Intelligence to Find Combination Drug Treatments for Covid-19
Healx, the AI-powered, patient-inspired biotech specialising in rare diseases, today announces it is using its […]
Twice Weekly Rapid Testing to be Available to Everyone in England
Everyone in England will be able to access free, regular, rapid coronavirus testing from 9 […]
Lilly, Vir, GSK Announce Positive Topline Data from Phase 2 BLAZE-4 Trial
Eli Lilly and Company (NYSE: LLY), Vir Biotechnology, Inc. (NASDAQ: VIR) and GlaxoSmithKline plc (LSE/NYSE: GSK) today announced […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more